Sort
48,018 grants matching “immunotherapy”
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2021 · OD
Novel mechanisms regulating PD-1 signaling and function
$423,750Adam Mor · New York University School Of Medicine · R01 · FY2017 · AI
Molecular Control of Plasmacytoid Dendritic Cell Development and Function
$423,750Boris Reizis · New York University School Of Medicine · R01 · FY2017 · AI
Myeloid Specific Targeted Nanoimunotherapy for Organ Transplant Acceptance
$423,750Jordi Ochando · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AI
Contribution of the cutaneous APC network to melanoma progression and therapy.
$423,750Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · CA
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2023 · OD
Epitope-Specific Targeting of Tau Aggregates.
$423,750Einar M Sigurdsson · New York University School Of Medicine · R01 · FY2018 · NS
Cytokine regulation of anti-helminth immunity
$423,750David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · AI
Innate immunity and inflammation following helminth infection
$423,750David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · AI
Epitope-Specific Targeting of Tau Aggregates.
$423,750Einar M Sigurdsson · New York University School Of Medicine · R01 · FY2017 · NS
Contribution of the cutaneous APC network to melanoma progression and therapy.
$423,750Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA
In vivo role of CTLA-4 in Costimulation and Autoimmunity
$423,750Arlene H Sharpe · Harvard Medical School · R01 · FY2015 · AI
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2019 · OD
INTERLEUKIN 2 IMMUNOTHERAPY FOR HCV INFECTION
$423,750Weill Medical College Of Cornell Univ · U01 · FY2000 · AI
Hiv Immune Reactivity 'in Vivo'and 'In Vitro'
$423,750Weill Medical College Of Cornell Univ · R01 · FY2002 · AI
Epitope-Specific Targeting of Tau Aggregates.
$423,750Einar M Sigurdsson · New York University School Of Medicine · R01 · FY2021 · NS
Regulation and function of innate lymphoid cells in the gut
$423,750David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AI
In vivo role of CTLA-4 in Costimulation and Autoimmunity
$423,750Arlene H Sharpe · Harvard Medical School · R01 · FY2016 · AI
Myeloid Specific Targeted Nanoimunotherapy for Organ Transplant Acceptance
$423,750Jordi Ochando · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · AI
Epitope-Specific Targeting of Tau Aggregates.
$423,750Einar M Sigurdsson · New York University School Of Medicine · R01 · FY2020 · NS
Novel mechanisms regulating PD-1 signaling and function
$423,750Adam Mor · New York University School Of Medicine · R01 · FY2016 · AI
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2020 · OD
Protocol Review and Monitoring System
$423,736Jeffrey A Meyerhardt · Dana-Farber Cancer Inst · P30 · FY2025 · CA
Directing the metabolic fate of CAR T cells
$423,662Carl H. June · University Of Pennsylvania · R01 · FY2022 · CA
Genomics and Computational Biology Shared Resource
$423,648Kelly A Frazer · University Of California, San Diego · P30 · FY2024 · CA